| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Sr. Vice President &CMO | SVP, Chief Medical Officer
1 company
Allen Yang last filed a Form 4 in March 2023, as Sr. Vice President &CMO at XNCR. From December 2019 to March 2023, the filings on record show 0 open-market purchases and 6 sales.
Our model assigns Allen Yang a middling insider score of 65/100, based on 5 past trades. Over a 12-month horizon, 80.0% of those trades were profitable, with an average 12-month return of +18.0%.
At the last filing, the largest reported position was 73,364 shares of XNCR. The filings there lean toward selling, a net 17,541 shares.
Shares as reported in the last Form 4 for each company; the most recent is from March 2023. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 9, 2023 | XNCR Xencor Inc | Sr. Vice President &CMO | Sell | 1,094 | $29.88 | $32,687.95 | -1.5% | -8.4% | -17.7% | |
| Mar 6, 2023 | XNCR Xencor Inc | Sr. Vice President &CMO | Sell | 4,069 | $31.42 | $127,831.30 | -5.2% | -15.5% | -28.3% | |
| Dec 19, 2022 | XNCR Xencor Inc | Sr. Vice President &CMO | Sell | 3,737 | $27.00 | $100,910.21 | -5.6% | +10.8% | -18.3% | |
| Mar 9, 2022 | XNCR Xencor Inc | Sr. Vice President &CMO | Sell | 1,200 | $28.94 | $34,723.44 | -1.8% | -24.4% | +2.0% | |
| Dec 17, 2021 | XNCR Xencor Inc | Sr. Vice President &CMO | Sell | 3,664 | $36.62 | $134,177.51 | -9.6% | -25.2% | -27.9% | |
| Dec 17, 2020 | XNCR Xencor Inc | Sr. Vice President &CMO | Sell | 3,777 | $43.85 | $165,621.45 | -11.7% | - | - |